KyDo Therapeutics
Latest round
- Seed
Last raised
- Apr 2025
Total raised
- $5.1M
Investors
- 4
About KyDo Therapeutics
KyDo Therapeutics GmbH specializes in the development of novel small molecule inhibitors for cancer treatment. Founded in 2024, the company has undergone no major pivots in its business strategy. The firm was established in Dortmund, Germany, and has completed 1 deal to date.KyDo Therapeutics GmbH focuses on the development of novel covalent-allosteric small molecule inhibitors, specifically targeting oncology applications. Their core product offerings are designed to tackle challenging cancer variants, with the goal of creating first-in-class drugs that could significantly improve treatment outcomes for patients. These inhibitors operate by modulating the activity of protein targets in a selective manner, thereby offering a therapeutic approach that may enhance efficacy while potentially reducing side effects. KyDo’s primary clients include pharmaceutical companies and research institutions in Europe and North America, where there is a significant demand for innovative cancer therapies.KyDo Therapeutics operates primarily through a B2B model, engaging in partnerships and collaborations to facilitate the advancement of its drug discovery platform. Revenue generation is structured around strategic alliances with larger pharmaceutical companies, which may involve milestone payments and royalties based on the successful development and commercialization of their inhibitors. Additionally, the company may engage in direct agreements with research institutions for the use of its proprietary technologies in preclinical studies. Although specific pricing plans for their products have not been disclosed, the typical structure for such transactions would include upfront fees for access to the technology, followed by performance-based payments contingent on achieving defined development milestones. The company is focused on the development of new oncology products and plans to expand its reach into specific markets in Europe and North America.
Who invested in KyDo Therapeutics
4 investors across 1 round
See all investors in KyDo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 29, 2025
Amount
$5.1M
Investors
Questions about KyDo Therapeutics
Who invested in KyDo Therapeutics?
KyDo Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KyDo Therapeutics raised?
KyDo Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did KyDo Therapeutics last raise money?
KyDo Therapeutics's most recent round on record is a Seed, in Apr 2025.
What does KyDo Therapeutics do?
KyDo Therapeutics GmbH specializes in the development of novel small molecule inhibitors for cancer treatment.
Where is KyDo Therapeutics headquartered?
KyDo Therapeutics is headquartered in Dortmund, Germany.
Which VCs invest in companies like KyDo Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at KyDo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like KyDo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.